摘要
目的探讨羚珠助眠胶囊治疗失眠的临床疗效。方法将120例符合标准的失眠病人随机分为治疗组和对照组,各60例。治疗组给予羚珠助眠胶囊口服,对照组给予阿普唑仑片口服,疗程为4周,观察两组临床疗效及治疗前后匹兹堡睡眠质量指数量表(PSQI)积分,并观察不良反应副反应量表(TESS)总分。结果治疗后,治疗组临床疗效、PSQI积分明显优于对照组(P <0.05),TESS总分明显低于对照组(P <0.05)。结论羚珠助眠胶囊治疗失眠,具有较好的临床疗效。
Objective To investigate the effect of Lingzhu Zhumian capsule(LZC)in the treatment of insomnia.Methods One hundredand twenty patients with insomnia were randomly divided into two groups:treatment group(n =60)treated with LZC,and control group(n =60)treated with alprazolam tablets for 4 weeks.Before and after treatment,Pittsburgh Sleep Quality index Scale(PSQI)score,andTreatment Emergent Symptom Scale(TESS)score were observed.Results After treatment,the clinical efficacy and PSQI score in thetreatment group were significantly better than those in the control group(P <0.05).The total score of TESS in the treatment group wassignificantly lower than that in the control group(P <0.05).Conclusion LZC has good clinical curative effect and high safety in patientswith insomnia.
作者
巩克波
刘远昌
高磊
武志华
孙晓卫
Gong Kebo;Liu Yuanchang;Gao Lei;Wu Zhihua;Sun Xiaowei(Jinan Children′s Hospital,Jinan 250022,Shandong,China)
出处
《中西医结合心脑血管病杂志》
2018年第24期3701-3704,共4页
Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词
失眠
肝肾阴虚
羚珠助眠胶囊
匹兹堡睡眠质量指数量表
不良反应副反应量表
insomnia
liver and kidney yin deficiency syndrome
Lingzhu Zhumian capsule
Pittsburgh Sleep Quality index Scale
the reaction volume the score table
